1. Home
  2. ALRN vs DGHI Comparison

ALRN vs DGHI Comparison

Compare ALRN & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRN
  • DGHI
  • Stock Information
  • Founded
  • ALRN 2001
  • DGHI 2017
  • Country
  • ALRN United States
  • DGHI United States
  • Employees
  • ALRN N/A
  • DGHI N/A
  • Industry
  • ALRN Biotechnology: Pharmaceutical Preparations
  • DGHI Finance: Consumer Services
  • Sector
  • ALRN Health Care
  • DGHI Finance
  • Exchange
  • ALRN Nasdaq
  • DGHI Nasdaq
  • Market Cap
  • ALRN 76.9M
  • DGHI 61.7M
  • IPO Year
  • ALRN 2017
  • DGHI N/A
  • Fundamental
  • Price
  • ALRN $1.97
  • DGHI $2.22
  • Analyst Decision
  • ALRN Strong Buy
  • DGHI Strong Buy
  • Analyst Count
  • ALRN 1
  • DGHI 1
  • Target Price
  • ALRN $19.00
  • DGHI $2.50
  • AVG Volume (30 Days)
  • ALRN 137.2K
  • DGHI 305.5K
  • Earning Date
  • ALRN 11-14-2024
  • DGHI 11-15-2024
  • Dividend Yield
  • ALRN N/A
  • DGHI N/A
  • EPS Growth
  • ALRN N/A
  • DGHI N/A
  • EPS
  • ALRN N/A
  • DGHI N/A
  • Revenue
  • ALRN N/A
  • DGHI $42,146,057.00
  • Revenue This Year
  • ALRN N/A
  • DGHI N/A
  • Revenue Next Year
  • ALRN N/A
  • DGHI N/A
  • P/E Ratio
  • ALRN N/A
  • DGHI N/A
  • Revenue Growth
  • ALRN N/A
  • DGHI 100.56
  • 52 Week Low
  • ALRN $1.61
  • DGHI $0.84
  • 52 Week High
  • ALRN $7.42
  • DGHI $2.34
  • Technical
  • Relative Strength Index (RSI)
  • ALRN 41.44
  • DGHI 66.00
  • Support Level
  • ALRN $1.90
  • DGHI $1.41
  • Resistance Level
  • ALRN $2.17
  • DGHI $1.74
  • Average True Range (ATR)
  • ALRN 0.18
  • DGHI 0.18
  • MACD
  • ALRN 0.02
  • DGHI 0.05
  • Stochastic Oscillator
  • ALRN 23.27
  • DGHI 87.10

About ALRN Aileron Therapeutics Inc.

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

Share on Social Networks: